The latest closing stock price for Eliem Therapeutics as of October 04, 2024 is 5.16.
An investor who bought $1,000 worth of Eliem Therapeutics stock at the IPO in 2021 would have $-675 today, roughly -1 times their original investment - a -31.28% compound annual growth rate over 3 years.
The all-time high Eliem Therapeutics stock closing price was 28.61 on September 07, 2021.
The Eliem Therapeutics 52-week high stock price is 11.55, which is 123.8% above the current share price.
The Eliem Therapeutics 52-week low stock price is 2.35, which is 54.5% below the current share price.
The average Eliem Therapeutics stock price for the last 52 weeks is 4.85.
An investor who bought $1,000 worth of Eliem Therapeutics stock at the IPO in 2021 would have $-675 today, roughly -1 times their original investment - a -31.28% compound annual growth rate over 3 years.
The all-time high Eliem Therapeutics stock closing price was 28.61 on September 07, 2021.
The Eliem Therapeutics 52-week high stock price is 11.55, which is 123.8% above the current share price.
The Eliem Therapeutics 52-week low stock price is 2.35, which is 54.5% below the current share price.
The average Eliem Therapeutics stock price for the last 52 weeks is 4.85.